AusperBio
Signal active
Organization
Contact Information
Overview
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
About
Industries
Biotechnology, Pharmaceutical, Biopharma
Founded
2019
Employees
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
AusperBio headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Biopharma sector. The company focuses on Biotechnology and has secured $1.2B in funding across 24 round(s). With a team of 101-250 employees, AusperBio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - AusperBio, raised $37.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
5
Lead Investors
0
Total Funding Amount
$50.7M
Details
2
AusperBio has raised a total of $50.7M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 13.7M | ||
| 2024 | Early Stage Venture | 37.0M |
Investors
AusperBio is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Genesis Capital | - | FUNDING ROUND - Genesis Capital | 37.0M |
| AusperBio | - | FUNDING ROUND - AusperBio | 37.0M |
| BioVenture | - | FUNDING ROUND - BioVenture | 37.0M |
| AusperBio | - | FUNDING ROUND - AusperBio | 37.0M |
Recent Activity
There is no recent news or activity for this profile.